Advanced Search

Show simple item record

dc.contributor.authorKarataş, Mert Olgun
dc.contributor.authorUslu, Harun
dc.contributor.authorSarı, Suat
dc.contributor.authorAlagöz, Mehmet Abdullah
dc.contributor.authorKarakurt, Arzu
dc.contributor.authorAlıcı, Bülent
dc.contributor.authorBilen, Çiğdem
dc.contributor.authorYavuz, Emre
dc.date.accessioned2019-10-17T11:06:52Z
dc.date.available2019-10-17T11:06:52Z
dc.date.issued2016en_US
dc.identifier.issn1475-6366
dc.identifier.issn1475-6374
dc.identifier.urihttps://doi.org/ 10.3109/14756366.2015.1063624
dc.identifier.urihttps://hdl.handle.net/20.500.12462/8439
dc.descriptionBilen, Çiğdem (Balikesir Author)en_US
dc.description.abstractAmong many others, coumarin derivatives are known to show human carbonic anhydrase (hCA) inhibitory activity. Since hCA inhibition is one of the underlying mechanisms that account for the activities of some antiepileptic drugs (AEDs), hCA inhibitors are expected to have anti-seizure properties. There are also several studies reporting compounds with an imidazole and/or benzimidazole moiety which exert these pharmacological properties. In this study, we prepared fifteen novel coumarin-bearing imidazolium and benzimidazolium chloride, nine novel benzoxazinone-bearing imidazolium and benzimidazolium chloride derivatives and evaluated their hCA inhibitory activities and along with fourteen previously synthesized derivatives we scanned their anticonvulsant effects. As all compounds inhibited purified hCA isoforms I and II, some of them also proved protective against Maximal electroshock seizure (MES) and ScMet induced seizures in mice. Molecular docking studies with selected coumarin derivatives have revealed that these compounds bind to the active pocket of the enzyme in a similar fashion to that previously described for coumarin derivatives.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.isversionof10.3109/14756366.2015.1063624en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnticonvulsanten_US
dc.subjectBenzoxazinoneen_US
dc.subjectCarbonic Anhydraseen_US
dc.subjectCoumarinen_US
dc.subjectEpilepsyen_US
dc.subjectInhibitionen_US
dc.titleCoumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studiesen_US
dc.typearticleen_US
dc.relation.journalJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.contributor.departmentFen Edebiyat Fakültesien_US
dc.contributor.authorIDhttp://orcid.org/0000-0001-8827-8557en_US
dc.contributor.authorIDhttp://orcid.org/0000-0001-8827-8557en_US
dc.contributor.authorIDhttp://orcid.org/0000-0002-8248-4218en_US
dc.identifier.volume31en_US
dc.identifier.issue5en_US
dc.identifier.startpage760en_US
dc.identifier.endpage772en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record